Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

CJC-1295 Vial Size Comparison

2mg 2mL 1mg/mL (1000mcg/mL) 50–200mcg per dose 6–8 weeks (twice weekly at 200mcg) Single vial, 28-day stability window covers full protocol 5mg 2.5mg/mL (2500mcg/mL) 100–300mcg per dose 10–12 weeks (twice weekly at 200mcg) May require staggered reconstitution

This comparison does not assign a generated winner or score.

  • 2mg
  • 2mL
  • 1mg/mL (1000mcg/mL)
  • 50–200mcg per dose
  • 6–8 weeks (twice weekly at 200mcg)
  • Single vial, 28-day stability window covers full protocol
  • 5mg
  • 2.5mg/mL (2500mcg/mL)
  • 100–300mcg per dose
  • 10–12 weeks (twice weekly at 200mcg)
  • May require staggered reconstitution if protocol exceeds 28 days
  • 5mL
  • Higher solution volume increases contamination risk over extended use
  • 10mg
  • 5mg/mL (5000mcg/mL)
  • 200–500mcg per dose
  • 16+ weeks or high-frequency protocols
  • Concentration too high for precise low-dose work; best for bulk studies
More references

Related material